Report : Europe Organ Care Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Modality (Trolley and Portable), Organ Type (Kidney, Liver, Heart, Lungs, and Others), and End User (Hospitals, Ambulatory Surgical Centers, and Others)
Trolley Segment to Dominate Europe Organ Care Products Market during 2020–2028
According to a new market research study on “Europe Organ Care Products Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Modality, Organ Type, and End User” is expected to reach US$ 73.97 million by 2028 from 27.67 US$ million in 2021. The market is estimated to grow at a CAGR of 15.1% from 2021 to 2028. The report provides trends prevailing in the Europe organ care products market along with the drivers and restraints pertaining to the market growth. Organ care products witnessing new product launches and product approvals is the major factor driving the growth of the Europe organ care products market. However, issues associated with high cost of organ transplantation and various kinds of cultural barriers hinders the growth of Europe organ care products market.
The Europe organ care products market is segmented into modality, organ type, end user, and country. Based on modality, the market is segmented into trolley and portable. In 2021, the trolley segment held a larger share of the market. In terms of organ type, the market is segmented into kidney, liver, heart, lungs, and others. In 2021, the kidney segment held the largest market share. Based on end user, the market is segmented into hospitals, ambulatory surgical centers, and others. In 2021, the hospitals segment held the largest share of the market. Based on country, the Europe organ care products market is segmented into France, Germany, Italy, Spain, the UK, and the Rest of Europe.
Accord Healthcare; Bridge to Life Ltd; Dr. Franz Koehler Chemie GmbH; Organ Recovery Systems; OrganOx Limited; Paragonix Technologies, Inc; Preservation Solutions, Inc.; TransMedics; Waters Medical Systems LLC; and XVIVO Perfusion are among the leading companies in the Europe organ care products market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, TransMedics Announces the Second FDA PMA Approval for its OCS Lung System, Allowing Access to a Larger Pool of Donor Lungs that are Currently Seldomly Utilized for Transplantation Due to Limitations of Cold Storage.
Contact Person: Sameer Joshi
Email Id: firstname.lastname@example.org